Illumina price target raised to $130-$135 from $90-$95 at Wells Fargo Wells Fargo increased its price target on Illumina after the company provided higher than expected 2014 revenue guidance and introduced two new systems. The firm believes that the company's position in the high-throughput sequencing and low/mid-throughput market has been enhanced. It keeps an Outperform rating on the shares.
News For ILMN From The Last 14 Days
Check below for free stories on ILMN the last two weeks.
Illumina price target raised to $195 from $180 at Leerink Leerink raised its price target for Illumina shares to $195 citing continued instrument momentum following the company's Q2 results. The firm keeps an Outperform rating on the stock.